Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Boerwinkle

Showing results (81-90 of 174) with videos related to

Pageof 18
Sort By:
Clinical Genetics|June 1, 1990
Frequency and effects of the apolipoprotein A-IV polymorphismS Visvikis, J Steinmetz, E Boerwinkle, et al.
The Journal of Clinical Investigation|July 1, 1992
Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrationsE Boerwinkle, C C Leffert, J Lin, et al.
Stroke|April 3, 2001
G-protein beta3 subunit and alpha-adducin polymorphisms and risk of subclinical and clinical strokeA C Morrison, P A Doris, A R Folsom, et al.
Circulation|March 14, 2001
Thrombomodulin Ala455Val polymorphism and risk of coronary heart diseaseK K Wu, N Aleksic, C Ahn, et al.
American Journal of Medical Genetics|July 1, 1987
The use of measured genotype information in the analysis of quantitative phenotypes in man. II. The role of the apolipoprotein E polymorphism in determining levels, variability, and covariability of cholesterol, betalipoprotein, and triglycerides in a sample of unrelated individualsE Boerwinkle, S Visvikis, D Welsh, et al.
Annals of Human Genetics|March 14, 2001
Analysis of lipoprotein lipase haplotypes reveals associations not apparent from analysis of the constituent lociD M Hallman, B E Groenemeijer, J W Jukema, et al.
Diabetologia|April 26, 2008
TCF7L2 single nucleotide polymorphisms, cardiovascular disease and all-cause mortality: the Atherosclerosis Risk in Communities (ARIC) studyS J Bielinski, J S Pankow, A R Folsom, et al.
Journal of Hypertension|February 24, 2001
Antihypertensive pharmacogenetics: getting the right drug into the right patientS T Turner, G L Schwartz, A B Chapman, et al.
Genetic Epidemiology|January 1, 1986
Analysis of the distribution of erythrocyte sodium lithium countertransport in a sample representative of the general populationE Boerwinkle, S T Turner, R Weinshilboum, et al.
Mayo Clinic Proceedings|September 19, 2001
Validity of the aldosterone-renin ratio used to screen for primary aldosteronismV M Montori, G L Schwartz, A B Chapman, et al.
Pageof 18

Showing results (81-90 of 174) with videos related to

Sort By:
Pageof 18
Clinical Genetics|June 1, 1990
Frequency and effects of the apolipoprotein A-IV polymorphismS Visvikis, J Steinmetz, E Boerwinkle, et al.
The Journal of Clinical Investigation|July 1, 1992
Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrationsE Boerwinkle, C C Leffert, J Lin, et al.
Stroke|April 3, 2001
G-protein beta3 subunit and alpha-adducin polymorphisms and risk of subclinical and clinical strokeA C Morrison, P A Doris, A R Folsom, et al.
Circulation|March 14, 2001
Thrombomodulin Ala455Val polymorphism and risk of coronary heart diseaseK K Wu, N Aleksic, C Ahn, et al.
American Journal of Medical Genetics|July 1, 1987
The use of measured genotype information in the analysis of quantitative phenotypes in man. II. The role of the apolipoprotein E polymorphism in determining levels, variability, and covariability of cholesterol, betalipoprotein, and triglycerides in a sample of unrelated individualsE Boerwinkle, S Visvikis, D Welsh, et al.
Annals of Human Genetics|March 14, 2001
Analysis of lipoprotein lipase haplotypes reveals associations not apparent from analysis of the constituent lociD M Hallman, B E Groenemeijer, J W Jukema, et al.
Diabetologia|April 26, 2008
TCF7L2 single nucleotide polymorphisms, cardiovascular disease and all-cause mortality: the Atherosclerosis Risk in Communities (ARIC) studyS J Bielinski, J S Pankow, A R Folsom, et al.
Journal of Hypertension|February 24, 2001
Antihypertensive pharmacogenetics: getting the right drug into the right patientS T Turner, G L Schwartz, A B Chapman, et al.
Genetic Epidemiology|January 1, 1986
Analysis of the distribution of erythrocyte sodium lithium countertransport in a sample representative of the general populationE Boerwinkle, S T Turner, R Weinshilboum, et al.
Mayo Clinic Proceedings|September 19, 2001
Validity of the aldosterone-renin ratio used to screen for primary aldosteronismV M Montori, G L Schwartz, A B Chapman, et al.
Pageof 18